The Paradoxical Role of Uric Acid in Osteoporosis.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing biological mechanisms and clinical associations without primary human data or systematic review methodology.
PubMed 31491937 · doi:10.3390/nu11092111
What was done
This narrative review synthesized existing literature on the biological mechanisms and clinical associations connecting uric acid levels to bone mineral density, bone turnover pathways, and fracture risk.
What was found
The abstract reports no numerical data, sample sizes, or effect estimates. Qualitatively, the review describes a dual role for uric acid: extracellular uric acid acts as an antioxidant and is associated with protection against bone fracture at normal to high physiological levels. However, intracellular degradation produces reactive oxygen species via NADPH oxidase, promoting inflammatory cytokines that enhance osteoclast bone resorption and suppress osteoblast bone formation. Uric acid also inhibits vitamin D production, provoking secondary hyperparathyroidism and reducing ABCG2-mediated urate excretion, which exacerbates bone loss and increases fracture risk in hyperuricemia and gout.
Why it matters
It outlines the dual biological pathways through which uric acid influences skeletal metabolism, helping explain conflicting observational findings on uric acid and fracture risk.
Limits
The abstract contains no quantitative metrics or systematic search criteria. As a narrative review, it relies on theoretical mechanistic pathways and does not assess clinical effect sizes, confounding variables, or population-level thresholds.
Cited by
- context Intracellular uric acid stimulates oxidative stress across virtually every cell type.